AgraTech, a biotech enterprise, is a producer of chitosan, a specialty chemical derived from crustacean waste, and a R&D company that develops chitosan-based products for industrial, consumer, pharmaceutical, and agricultural markets. Chitosan, a renewable natural resource, is a non-toxic, non-hazardous, and biodegradable material that has many commercial applications. Demand for chitosan is expected to reach 42,950 metric tons by 2020. Through its manufacturing subsidiary, KYTOSAN USA, LLC, AgraTech will be the sole domestic commercial supplier of consistently high quality industrial-grade chitosan. The chitosan manufacturing facility will be located in the Opelousas Industrial Park in Opelousas, LA. Crustacean waste is abundantly available year-round in this region of the state.
AgraTech’s R&D laboratory is located at Cade Farm, an agricultural research facility for the University of Louisiana at Lafayette, where our Chief Technology Officer collaborates with other scientists and engineers developing patentable chitosan-based products. AgraTech has already developed intellectual properties and has secured patents for some of them domestically and internationally. These chitosan-based products, which are in their final stages of development, include a resorbable dental membrane; a permanent water-repellant shield for glass surfaces; and a hemostatic nasal spray to stop nose bleeds. To maximize profitability for each product, AgraTech will either form a production and marketing subsidiary or license the technology to other firms for a fee plus royalties.